Animal Model Market By Animal Type (Rat, Mice, Guinea pigs, Rabbits, Others), By Application (Drug discovery and development, Basic research, Others), By End User (Pharma and biotech companies, Academic research institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Animal Model Market

The animal model market is likely to experience a significant growth rate of 6.6% from 2022-2032 owing to surge in use of animal models in virology and infectious diseases, physiological similarity of humans and animals for drug testing, increase in adoption of CRISPR technology –  

An animal model refers to the use of non-human organisms, typically animals, to simulate or mimic aspects of human biology, physiology, and disease in scientific research. These models play a crucial role in various fields, such as biomedical research, pharmaceutical development, genetics, and behavioral studies.  

Key factors driving the growth of animal model market include Rise in usage of animal models in virology and infectious diseases, physiological similarity of humans and animals for drug testing, increase in adoption of CRISPR technology.  

Rise in usage of animal models in virology and infectious diseases research is expected to drive the growth of the market. With the emergence of various viral diseases and infectious pathogens, there has been a growing need for effective treatments and vaccines. Animal models have played a crucial role in understanding the pathogenesis of these diseases and testing potential therapeutic interventions. Researchers use animal models to study disease transmission, evaluate the efficacy of antiviral drugs, and assess the safety and immunogenicity of vaccines before proceeding to human trials. By providing valuable insights into disease mechanisms and treatment options, animal models have become an indispensable tool in virology and infectious diseases research. 

Furthermore, many animals, particularly mammals, share genetic, anatomical, and physiological features with humans, making them suitable proxies for studying human diseases and drug responses. The similarity allows researchers to predict potential drug effects, toxicity, and adverse reactions in humans more accurately. Moreover, using animal models in preclinical studies helps to refine drug candidates before they enter human clinical trials, reducing the risks and costs associated with drug development. In addition, one crucial aspect of physiological similarity is the genetic makeup shared between animals and humans. While not identical, there is considerable overlap in the genetic composition between various animal species and humans. This allows researchers to study the effects of drugs and investigate disease mechanisms in animals, gaining insights that can be applied to human biology. 

In addition, the advent of CRISPR technology has sparked a revolutionary transformation in the field of genetic engineering, propelling scientific advancements at an unprecedented pace. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a powerful gene-editing tool that enables researchers to precisely modify DNA sequences with remarkable efficiency and accuracy. CRISPR allows scientists to precisely edit the genomes of animals, creating genetically modified models that mimic human diseases more accurately. CRISPR-engineered animal models have become invaluable tools for studying human diseases and their underlying genetic mechanisms. Researchers can now replicate specific genetic mutations associated with various conditions, enabling them to gain crucial insights into disease development and potential therapeutic interventions. Furthermore, CRISPR technology has enabled the creation of humanized animal models, where certain human genes or tissues are introduced into animals. This has proven instrumental in studying human-specific diseases and drug responses, leading to more accurate preclinical trials and drug testing. The ease and cost-effectiveness of CRISPR technology have led to its widespread adoption in laboratories worldwide, contributing to the growth of the animal model market. 

Thus, the animal model market is expected to achieve robust growth driven by factors such as the increased usage of animal models in virology and infectious diseases research, the physiological similarity of animals to humans for drug testing, and the growing adoption of CRISPR technology in animal model development 

The global animal model market is segmented into animal type, application, end user, and region. On the basis of animal type, the market is categorized into rat, mice, guinea pigs, rabbits, and others. The others include zebrafish, amphibians & reptiles, hamsters, chinchillas, gerbils, and armadillo. By application, the market is divided into drug discovery & development, basic research, and others. The others include medical device development, and production & quality control. Depending on end user, the market is segregated into pharma & biotech companies, academic research institutes, and others. The others segment includes medical device companies, contract research organizations (CROs), and contract manufacturing organizations. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

The key players profiled in the study include The Jackson Laboratory, Janvier Labs, LLC, Genoway S.A., Hera Biolabs, Crown Bioscience Inc, Ozgene Pty Ltd., Taconic Biosciences, Trans Genic Inc., Inotiv, Inc., and Charles River Laboratories. 

 

Key Market Insights  

By animal type, the mice segment was the highest revenue contributor to the market in 2022 and is estimated to reach $2236.42 million by 2032. 

By application, the drug discovery & development segment held the largest market share  

 in 2022. 

By end user, the pharma & biotech companies segment held the largest market share in 2022. 

Region wise, North America registered the highest market share in 2022. However, Asia-Pacific is expected to exhibit fastest growth during the forecast period.  

Overview

The animal model market was valued for $1,905.61 million in 2022 and is estimated to reach $3,617.92 million by 2032, exhibiting a CAGR of 6.6% from 2023 to 2032. 

Animals that are genetically engineered for research as well as biological and pathological studies are referred to as animal models. Animal models such as rat, mice, guinea pigs, and rabbits are used to study the development & advancement of various diseases and test new treatment methods before conducting human trials, as they exhibit functional similarity to the human body. However, there are several animal welfare guidelines that have to be followed while using animal models for experiments. Surge in use of animal models in virology and infectious diseases, increase in adoption of CRISPR technology, and rise in number of R&D activities are driving the growth of animal model market. 

Vaccines are the most effective and economical tools in preventing and controlling infectious diseases. Owing to the rapid spread of SARS-CoV-2, the variability among clinical cases, their outcomes, and high mortality rates, a race to find pharmacological treatments and vaccines was initiated once the World Health Organization (WHO) declared COVID-19 a public health emergency of international concern in January 2020 and a pandemic in March 2020. In context, of vaccine development for COVID-19, the use and choice of reliable and well-characterized experimental models were important for the rapid advancement of research and, consequently, the registration and availability of the vaccines. According to a 2021 report by the National Library of Medicines, animal models involved in the study of COVID-19 include mice, golden hamsters, ferrets, nonhuman primates, and pigs. More than 302 vaccines were under development, of which 117 of them have successfully entered clinical trials. Thus, increase in usage of animal models in the development of vaccines for infectious diseases is expected to contribute significantly in the growth of the market.

Increased adoption of CRISPR (clustered regularly interspaced short palindromic repeats) technology has emerged as a major driver of the animal model market. CRISPR technology allows for precise and efficient genome editing by enabling scientists to make targeted modifications in the DNA of various organisms, including animals. This revolutionary gene-editing tool has significantly advanced the field of genetics and biomedical research, offering numerous applications in the creation of animal models. Furthermore, animal models generated by CRISPR technology have been crucial in the discovery of new medicines. This technology generates highly customized mice and rats whose DNA has been altered to reflect a humanized immune system, which enables precision modeling in research as well as target validation and efficacy assessment. Prior to the use of this technology, it took up to 18 months to produce test animals, whereas now it takes anywhere from one-third to one-half the time to create a founder animal, making it more cost-effective than alternative preclinical animal models. Thus, rise in adoption CRISPR and increase in mouse model-based research are expected to drive the growth of the market. For instance, the U.S. medical and health research and development investment reached $245.1 billion in 2020, an 11.1% increase in 2020. Increase in research activities in the mice model to effectively use them in drug development process is expected to drive the growth of the market. However, ethical guidelines for the use of animals in research are expected to restrain the growth of the animal model market.

The global animal model market is segmented into animal type, application, end user, and region. On the basis of animal type, the market is categorized into rat, mice, guinea pigs, rabbits, and others. The others include zebrafish, amphibians & reptiles, hamsters, chinchillas, gerbils, and armadillo. By application, the market is divided into drug discovery & development, basic research, and others. The others include medical device development, and production & quality control. Depending on end user, the market is segregated into pharma & biotech companies, academic research institutes, and others. The others segment includes medical device companies, contract research organizations (CROs), and contract manufacturing organizations. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA

The key players that operate in the global animal model market are The Jackson Laboratory, Janvier Labs, LLC, Genoway S.A., Hera Biolabs, Crown Bioscience Inc, Ozgene Pty Ltd., Taconic Biosciences, Trans Genic Inc., Inotiv, Inc., and Charles River Laboratories.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the animal model market analysis from 2022 to 2032 to identify the prevailing animal model market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the animal model market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global animal model market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

● Additional company profiles with specific to client's interest

● Additional country or region analysis- market size and forecast

Key Market Segments

○ Genoway S.A

Scope of Animal Model Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Low bargaining power of suppliers

3.3.2. Low threat of new entrants

3.3.3. Low threat of substitutes

3.3.4. Low intensity of rivalry

3.3.5. Low bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in usage of animal models in virology and infectious diseases

3.4.1.2. Physiological similarity of humans and animals for drug testing

3.4.1.3. Increase in adoption of CRISPR technology

3.4.2. Restraints

3.4.2.1. Availability of alternative testing methods

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets

4.1. Overview

4.1.1. Market size and forecast

4.2. Rat

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Mice

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Guinea pigs

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Rabbits

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

4.6. Others

4.6.1. Key market trends, growth factors and opportunities

4.6.2. Market size and forecast, by region

4.6.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Drug discovery and development

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Basic research

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Pharma and biotech companies

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Academic research institutes

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Others

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by Animal Type

7.2.3. Market size and forecast, by Application

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by Animal Type

7.2.5.1.2. Market size and forecast, by Application

7.2.5.1.3. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by Animal Type

7.2.5.2.2. Market size and forecast, by Application

7.2.5.2.3. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Market size and forecast, by Animal Type

7.2.5.3.2. Market size and forecast, by Application

7.2.5.3.3. Market size and forecast, by End User

7.3. Europe

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by Animal Type

7.3.3. Market size and forecast, by Application

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by Animal Type

7.3.5.1.2. Market size and forecast, by Application

7.3.5.1.3. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Market size and forecast, by Animal Type

7.3.5.2.2. Market size and forecast, by Application

7.3.5.2.3. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Market size and forecast, by Animal Type

7.3.5.3.2. Market size and forecast, by Application

7.3.5.3.3. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Market size and forecast, by Animal Type

7.3.5.4.2. Market size and forecast, by Application

7.3.5.4.3. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Market size and forecast, by Animal Type

7.3.5.5.2. Market size and forecast, by Application

7.3.5.5.3. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Market size and forecast, by Animal Type

7.3.5.6.2. Market size and forecast, by Application

7.3.5.6.3. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by Animal Type

7.4.3. Market size and forecast, by Application

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Market size and forecast, by Animal Type

7.4.5.1.2. Market size and forecast, by Application

7.4.5.1.3. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Market size and forecast, by Animal Type

7.4.5.2.2. Market size and forecast, by Application

7.4.5.2.3. Market size and forecast, by End User

7.4.5.3. Australia

7.4.5.3.1. Market size and forecast, by Animal Type

7.4.5.3.2. Market size and forecast, by Application

7.4.5.3.3. Market size and forecast, by End User

7.4.5.4. India

7.4.5.4.1. Market size and forecast, by Animal Type

7.4.5.4.2. Market size and forecast, by Application

7.4.5.4.3. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Market size and forecast, by Animal Type

7.4.5.5.2. Market size and forecast, by Application

7.4.5.5.3. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Market size and forecast, by Animal Type

7.4.5.6.2. Market size and forecast, by Application

7.4.5.6.3. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key market trends, growth factors and opportunities

7.5.2. Market size and forecast, by Animal Type

7.5.3. Market size and forecast, by Application

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Market size and forecast, by Animal Type

7.5.5.1.2. Market size and forecast, by Application

7.5.5.1.3. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Market size and forecast, by Animal Type

7.5.5.2.2. Market size and forecast, by Application

7.5.5.2.3. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Market size and forecast, by Animal Type

7.5.5.3.2. Market size and forecast, by Application

7.5.5.3.3. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Market size and forecast, by Animal Type

7.5.5.4.2. Market size and forecast, by Application

7.5.5.4.3. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2022

9.1. Charles River Laboratories

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Business performance

9.1.7. Key strategic moves and developments

9.2. Inotiv, Inc.

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Business performance

9.3. Genoway S.A.

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Key strategic moves and developments

9.4. Hera Biolabs

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.5. Crown Bioscience Inc.

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.6. Ozgene Pty Ltd.

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.7. Taconic Biosciences

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.7.6. Key strategic moves and developments

9.8. The Jackson Laboratory.

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.9. Trans Genic Inc.

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.10. Janvier Labs, LLC

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 02. ANIMAL MODEL MARKET FOR RAT, BY REGION, 2022-2032 ($MILLION)

TABLE 03. ANIMAL MODEL MARKET FOR MICE, BY REGION, 2022-2032 ($MILLION)

TABLE 04. ANIMAL MODEL MARKET FOR GUINEA PIGS, BY REGION, 2022-2032 ($MILLION)

TABLE 05. ANIMAL MODEL MARKET FOR RABBITS, BY REGION, 2022-2032 ($MILLION)

TABLE 06. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 07. GLOBAL ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 08. ANIMAL MODEL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)

TABLE 09. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2022-2032 ($MILLION)

TABLE 10. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 11. GLOBAL ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 12. ANIMAL MODEL MARKET FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)

TABLE 13. ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)

TABLE 14. ANIMAL MODEL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 15. ANIMAL MODEL MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 16. NORTH AMERICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 17. NORTH AMERICA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 18. NORTH AMERICA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 19. NORTH AMERICA ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 20. U.S. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 21. U.S. ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 22. U.S. ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 23. CANADA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 24. CANADA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 25. CANADA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 26. MEXICO ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 27. MEXICO ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 28. MEXICO ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 29. EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 30. EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 31. EUROPE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 32. EUROPE ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 33. GERMANY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 34. GERMANY ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 35. GERMANY ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 36. FRANCE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 37. FRANCE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 38. FRANCE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 39. UK ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 40. UK ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 41. UK ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 42. ITALY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 43. ITALY ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 44. ITALY ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 45. SPAIN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 46. SPAIN ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 47. SPAIN ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 48. REST OF EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 49. REST OF EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 50. REST OF EUROPE ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 51. ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 52. ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 53. ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 54. ASIA-PACIFIC ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 55. JAPAN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 56. JAPAN ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 57. JAPAN ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 58. CHINA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 59. CHINA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 60. CHINA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 61. AUSTRALIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 62. AUSTRALIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 63. AUSTRALIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 64. INDIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 65. INDIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 66. INDIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 67. SOUTH KOREA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 68. SOUTH KOREA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 69. SOUTH KOREA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 70. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 71. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 73. LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 74. LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 75. LAMEA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 76. LAMEA ANIMAL MODEL MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 77. BRAZIL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 78. BRAZIL ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 79. BRAZIL ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 80. SAUDI ARABIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 81. SAUDI ARABIA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 82. SAUDI ARABIA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 83. SOUTH AFRICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 84. SOUTH AFRICA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 85. SOUTH AFRICA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 86. REST OF LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022-2032 ($MILLION)

TABLE 87. REST OF LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2022-2032 ($MILLION)

TABLE 88. REST OF LAMEA ANIMAL MODEL MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 89. CHARLES RIVER LABORATORIES: KEY EXECUTIVES

TABLE 90. CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT

TABLE 91. CHARLES RIVER LABORATORIES: PRODUCT SEGMENTS

TABLE 92. CHARLES RIVER LABORATORIES: SERVICE SEGMENTS

TABLE 93. CHARLES RIVER LABORATORIES: PRODUCT PORTFOLIO

TABLE 94. CHARLES RIVER LABORATORIES: KEY STRATERGIES

TABLE 95. INOTIV, INC.: KEY EXECUTIVES

TABLE 96. INOTIV, INC.: COMPANY SNAPSHOT

TABLE 97. INOTIV, INC.: PRODUCT SEGMENTS

TABLE 98. INOTIV, INC.: PRODUCT PORTFOLIO

TABLE 99. GENOWAY S.A.: KEY EXECUTIVES

TABLE 100. GENOWAY S.A.: COMPANY SNAPSHOT

TABLE 101. GENOWAY S.A.: PRODUCT SEGMENTS

TABLE 102. GENOWAY S.A.: PRODUCT PORTFOLIO

TABLE 103. GENOWAY S.A.: KEY STRATERGIES

TABLE 104. HERA BIOLABS: KEY EXECUTIVES

TABLE 105. HERA BIOLABS: COMPANY SNAPSHOT

TABLE 106. HERA BIOLABS: PRODUCT SEGMENTS

TABLE 107. HERA BIOLABS: SERVICE SEGMENTS

TABLE 108. HERA BIOLABS: PRODUCT PORTFOLIO

TABLE 109. CROWN BIOSCIENCE INC.: KEY EXECUTIVES

TABLE 110. CROWN BIOSCIENCE INC.: COMPANY SNAPSHOT

TABLE 111. CROWN BIOSCIENCE INC.: PRODUCT SEGMENTS

TABLE 112. CROWN BIOSCIENCE INC.: SERVICE SEGMENTS

TABLE 113. CROWN BIOSCIENCE INC.: PRODUCT PORTFOLIO

TABLE 114. OZGENE PTY LTD.: KEY EXECUTIVES

TABLE 115. OZGENE PTY LTD.: COMPANY SNAPSHOT

TABLE 116. OZGENE PTY LTD.: PRODUCT SEGMENTS

TABLE 117. OZGENE PTY LTD.: SERVICE SEGMENTS

TABLE 118. OZGENE PTY LTD.: PRODUCT PORTFOLIO

TABLE 119. TACONIC BIOSCIENCES: KEY EXECUTIVES

TABLE 120. TACONIC BIOSCIENCES: COMPANY SNAPSHOT

TABLE 121. TACONIC BIOSCIENCES: PRODUCT SEGMENTS

TABLE 122. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO

TABLE 123. TACONIC BIOSCIENCES: KEY STRATERGIES

TABLE 124. THE JACKSON LABORATORY.: KEY EXECUTIVES

TABLE 125. THE JACKSON LABORATORY.: COMPANY SNAPSHOT

TABLE 126. THE JACKSON LABORATORY.: PRODUCT SEGMENTS

TABLE 127. THE JACKSON LABORATORY.: PRODUCT PORTFOLIO

TABLE 128. TRANS GENIC INC.: KEY EXECUTIVES

TABLE 129. TRANS GENIC INC.: COMPANY SNAPSHOT

TABLE 130. TRANS GENIC INC.: PRODUCT SEGMENTS

TABLE 131. TRANS GENIC INC.: PRODUCT PORTFOLIO

TABLE 132. JANVIER LABS, LLC: KEY EXECUTIVES

TABLE 133. JANVIER LABS, LLC: COMPANY SNAPSHOT

TABLE 134. JANVIER LABS, LLC: PRODUCT SEGMENTS

TABLE 135. JANVIER LABS, LLC: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. ANIMAL MODEL MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF ANIMAL MODEL MARKET,2022-2032

FIGURE 03. TOP INVESTMENT POCKETS IN ANIMAL MODEL MARKET (2023-2032)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW THREAT OF NEW ENTRANTS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW INTENSITY OF RIVALRY

FIGURE 08. LOW BARGAINING POWER OF BUYERS

FIGURE 09. GLOBAL ANIMAL MODEL MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 10. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2022 AND 2032(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR RAT, BY COUNTRY 2022 AND 2032(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR MICE, BY COUNTRY 2022 AND 2032(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR GUINEA PIGS, BY COUNTRY 2022 AND 2032(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR RABBITS, BY COUNTRY 2022 AND 2032(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 16. ANIMAL MODEL MARKET, BY APPLICATION, 2022 AND 2032(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. ANIMAL MODEL MARKET, BY END USER, 2022 AND 2032(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR PHARMA AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 24. ANIMAL MODEL MARKET BY REGION, 2022 AND 2032(%)

FIGURE 25. U.S. ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 26. CANADA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 27. MEXICO ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 28. GERMANY ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 29. FRANCE ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 30. UK ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 31. ITALY ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 32. SPAIN ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 33. REST OF EUROPE ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 34. JAPAN ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 35. CHINA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 36. AUSTRALIA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 37. INDIA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 38. SOUTH KOREA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 39. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 40. BRAZIL ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 41. SAUDI ARABIA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 42. SOUTH AFRICA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 43. REST OF LAMEA ANIMAL MODEL MARKET, 2022-2032 ($MILLION)

FIGURE 44. TOP WINNING STRATEGIES, BY YEAR (2020-2023)

FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)

FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)

FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 48. COMPETITIVE DASHBOARD

FIGURE 49. COMPETITIVE HEATMAP: ANIMAL MODEL MARKET

FIGURE 50. TOP PLAYER POSITIONING, 2022

FIGURE 51. CHARLES RIVER LABORATORIES: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 52. CHARLES RIVER LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 53. CHARLES RIVER LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 54. INOTIV, INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 55. INOTIV, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 56. INOTIV, INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 57. TRANS GENIC INC.: NET REVENUE, 2020-2022 ($MILLION